ClinicalTrials.Veeva

Menu

Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis

K

Karolinska University Hospital

Status

Completed

Conditions

Cystic Fibrosis

Treatments

Device: Bilevel
Device: PEP mask

Study type

Interventional

Funder types

Other

Identifiers

NCT02083263
CF2012-1

Details and patient eligibility

About

With the use of Non invasive ventilation the patients with cystic fibrosis will have better lung function (FEV1).

Full description

3 months intervention between PEP an Bilevel. The patients will follow up under 3 months.

Enrollment

32 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with CF older than 18 years
  • FEV1 between 20% and 69% of predictive.
  • No acute exacerbation.
  • No Burkhordelia Cepacia/MRSA colonization.

Exclusion criteria

  • Children under 18 year
  • acute exacerbation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

32 participants in 2 patient groups

Bilevel
Experimental group
Description:
Bilevel, 3 months. The treatment was performed twice a day, 1 hour each treatment.
Treatment:
Device: Bilevel
PEP mask
Active Comparator group
Description:
PEP mask, 3 months. The treatment was performed twice a day, 1 hour each treatment.
Treatment:
Device: PEP mask

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems